Ben Littauer | Boulder Peptide Symposium

September 15-18, 2025

LIVE, In Person at the St. Julien Hotel in Boulder, Colorado
The only conference focused solely on the pharmaceutical development of peptide therapeutics.

Ben Littauer

Ben Littauer

Ben Littauer

Angel Investor
Boston Harbor Angels and
Walnut Venture Associates

 

Ben Littauer is an angel investor with expertise in Internet and communications technologies, as well as healthcare IT.  Currently an active member of Boston Harbor Angels and Walnut Venture Associates with investments in a wide variety of startups, he sits on the boards of several portfolio companies. He is a mentor for Mass Challenge andThe Capital Network, and is on the advisory board at TCN. Mr. Littauer is a judge for Mass Challenge, CRDF Global, and various academic competitions.

Mr. Littauer was Technology Strategist for Beth Israel Deaconess Medical Center in Boston, where he defined the architecture for PatientSite, allowing patients to communicate securely with their healthcare team and view their own medical records.  He was a consultant to the Massachusetts Health Data Consortium on healthcare data security projects.

Mr. Littauer was co-founder, President, and CTO of Baranof Software, the leading vendor of service-level management software for messaging and Internet applications. Baranof was sold to Tally Systems in 1997.

He has worked for Cisco Systems, Sun Microsystems, Symantec, Lotus, and BBN. Mr. Littauer was also an analyst with Ferris Research and Baroudi Bloor International.


s2Member®
loading...